Hiroshi Numao

Aomori, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Competing risks of treatment discontinuation of atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma.

Competing risks of treatment discontinuation of atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma.

Journal: JHEP reports : innovation in hepatology

Published: March 10, 2026

Sequential Pancreatic Ascites and Hemosuccus Pancreaticus from an Identical Rupture Site in Branch-Duct Intraductal Papillary Mucinous Neoplasm: A Case Report.

Sequential Pancreatic Ascites and Hemosuccus Pancreaticus from an Identical Rupture Site in Branch-Duct Intraductal Papillary Mucinous Neoplasm: A Case Report.

Journal: Case reports in gastroenterology

Published: February 07, 2026

Successful Colonic Stenting Across the Ileocecal Valve With Severe Malignant Stenosis Using Ultra-thin Scope and Single-balloon Overtube.

Successful Colonic Stenting Across the Ileocecal Valve With Severe Malignant Stenosis Using Ultra-thin Scope and Single-balloon Overtube.

Journal: DEN open

Published: June 07, 2025

Optimizing Cabozantinib Dosing in Unresectable Hepatocellular Carcinoma of 7-on/7-off Regimen.

Optimizing Cabozantinib Dosing in Unresectable Hepatocellular Carcinoma of 7-on/7-off Regimen.

Journal: Cancers

Published: March 20, 2025

Hepatocellular carcinoma developing autoimmune hemolytic anemia after atezolizumab and bevacizumab combination therapy, transitioning to second-line treatment following improvement:a case report

Hepatocellular carcinoma developing autoimmune hemolytic anemia after atezolizumab and bevacizumab combination therapy, transitioning to second-line treatment following improvement:a case report

Journal: Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology

Published: February 09, 2025

A New Model to Predict Survival Time in Patients With Hepatocellular Carcinoma With BCLC Advanced Stage.

A New Model to Predict Survival Time in Patients With Hepatocellular Carcinoma With BCLC Advanced Stage.

Journal: Cancer medicine

Published: January 24, 2025

Relapsed refractory immune checkpoint inhibitor-induced colitis treated with tacrolimus and maintained with vedolizumab.

Relapsed refractory immune checkpoint inhibitor-induced colitis treated with tacrolimus and maintained with vedolizumab.

Journal: Clinical journal of gastroenterology

Published: December 02, 2024

Validation Study of Scores Predicting Hepatocellular Carcinoma Risk in Chronic Hepatitis B Patients Treated With Nucleos(t)ide Analogues.

Validation Study of Scores Predicting Hepatocellular Carcinoma Risk in Chronic Hepatitis B Patients Treated With Nucleos(t)ide Analogues.

Journal: Journal of viral hepatitis

Published: November 02, 2024

Morphological change of foveolar-type gastric adenocarcinoma after proton pump inhibitor discontinuation in a short time period: A case report.

Morphological change of foveolar-type gastric adenocarcinoma after proton pump inhibitor discontinuation in a short time period: A case report.

Journal: DEN open

Published: June 07, 2023

Gastric varices treated by balloon-occluded retrograde transvenous obliteration following oxaliplatin-based chemotherapy for gastric cancer

Gastric varices treated by balloon-occluded retrograde transvenous obliteration following oxaliplatin-based chemotherapy for gastric cancer

Journal: Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology

Published: May 14, 2023

A new model to estimate duration of survival in patients with hepatocellular carcinoma with BCLC intermediate stage.

A new model to estimate duration of survival in patients with hepatocellular carcinoma with BCLC intermediate stage.

Journal: Scientific reports

Published: February 24, 2023

Influence of skeletal muscle volume loss during lenvatinib treatment on prognosis in unresectable hepatocellular carcinoma: a multicenter study in Tohoku, Japan.

Influence of skeletal muscle volume loss during lenvatinib treatment on prognosis in unresectable hepatocellular carcinoma: a multicenter study in Tohoku, Japan.

Journal: Scientific reports

Published: February 04, 2022

Showing 1-12 of 17

Last Updated: 09/26/2026